| Detected | Trial | Change |
|---|---|---|
| 2026-06-03 | NCT03786783 Dinutuximab, Sargramostim, and Combination Chemotherapy in Treating Patients With Newly… |
Trial completed |
| 2026-06-03 | NCT03786783 Dinutuximab, Sargramostim, and Combination Chemotherapy in Treating Patients With Newly… |
date change Completion moved earlier: 2026-09-19 -> 2026-03-31 |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT06220032 | Prevention of Anthracycline-Induced Cardiac Dysfunction With Dexrazoxane in Patients With… | DLBCL - Diffuse Large B Cell Lymphoma | Recruiting |
| NCT03126916 | Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With… | Ganglioneuroblastoma | Recruiting |
| NCT04293562 | A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for… | Acute Myeloid Leukemia | Recruiting |
| NCT06647953 | Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary… | Pleuropulmonary Blastoma | Recruiting |
| NCT03020030 | Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Children and Adolescents | Acute Lymphoblastic Leukemia, Pediatric | Active, Not Recruiting |
| NCT00980460 | Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer | PRETEXT I Hepatoblastoma | Active, Not Recruiting |
| NCT03007147 | Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed… | Acute Lymphoblastic Leukemia | Active, Not Recruiting |
| Phase 2 | |||
| NCT03589729 | Dexrazoxane Hydrochloride in Preventing Heart-Related Side Effects of Chemotherapy in… | Acute Myeloid Leukemia | Recruiting |
| NCT01864109 | Irinotecan and Temozolomide in Combination With Existing High Dose Alkylator Based… | Newly Diagnosed Ewing Sarcoma | Active, Not Recruiting |
| NCT03164057 | A Trial of Epigenetic Priming in Patients With Newly Diagnosed Acute Myeloid Leukemia | Acute Myeloid Leukemia | Active, Not Recruiting |
| NCT01871766 | Risk-Adapted Focal Proton Beam Radiation and/or Surgery in Patients With Low… | Rhabdomyosarcoma | Active, Not Recruiting |
| NCT00077285 | Irinotecan and Carboplatin as Upfront Window Therapy in Treating Patients With Newly… | Sarcoma | Active, Not Recruiting |
| Phase 1 | |||
| NCT05292664 | Venetoclax Basket Trial for High Risk Hematologic Malignancies | Myelodysplastic Syndromes, de Novo | Recruiting |